NCT00626496Recruiting
Family Study of Lymphoproliferative Disorders
Genetic Epidemiology of Lymphoproliferative Disorders
Source: ClinicalTrials.gov · Last updated 2 Nov 2026
Brief summary (registry, in English)
Blood and lymph node cancers can begin in either the lymphatic tissues (as in the case of lymphoma) or in the bone marrow (as with leukemia and myeloma), and they all are involved with the uncontrolled growth of white blood cells. There are many subtypes of these cancers, e.g., chronic lymphocytic leukemia and non-Hodgkin lymphoma. Since there is evidence that these cancers cluster in families, this study aims to understand how genetics and environmental exposures contribute to the development of these cancers.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 3000 (estimated)
- First submitted
- 20 Feb 2008
- Start date
- 1 Apr 2004
- Primary completion date
- 31 Dec 2029
- Lead sponsor
- Mayo Clinic
- NCT number
- NCT00626496
What you commit to
- Study type: Observational
- Planned participants: 3000
- From 1 Apr 2004 to the primary completion date, 31 Dec 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- At least 2 living, blood related relatives, affected with a lymphoproliferative disorder.
Age in the registry: 18 years to 100 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic Coordinator of this site? Confirm its status | Rochester | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.